These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 38941280)

  • 21. Hepatitis C virus infection and risk of liver-related and non-liver-related deaths: a population-based cohort study in Naples, southern Italy.
    Piselli P; Serraino D; Fusco M; Girardi E; Pirozzi A; Toffolutti F; Cimaglia C; Taborelli M;
    BMC Infect Dis; 2021 Jul; 21(1):667. PubMed ID: 34238231
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalence, estimated incidence, risk behaviours, and genotypic distribution of hepatitis C virus among people who inject drugs accessing harm-reduction services in Kenya: a retrospective cohort study.
    Akiyama MJ; Cleland CM; Lizcano JA; Cherutich P; Kurth AE
    Lancet Infect Dis; 2019 Nov; 19(11):1255-1263. PubMed ID: 31540840
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevalence of human immunodeficiency virus, hepatitis B virus, hepatitis C virus and syphilis among prison inmates and officers at Nsawam and Accra, Ghana.
    Adjei AA; Armah HB; Gbagbo F; Ampofo WK; Quaye IKE; Hesse IFA; Mensah G
    J Med Microbiol; 2006 May; 55(Pt 5):593-597. PubMed ID: 16585647
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sero-prevalence and associated risk factors for hepatitis C virus infection among voluntary counseling testing and anti retroviral treatment clinic attendants in Adwa hospital, northern Ethiopia.
    Atsbaha AH; Asmelash Dejen T; Belodu R; Getachew K; Saravanan M; Wasihun AG
    BMC Res Notes; 2016 Feb; 9():121. PubMed ID: 26905429
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hepatitis C viraemic and seroprevalence and risk factors for positivity in Northwest Cambodia: a household cross-sectional serosurvey.
    Lynch E; Falq G; Sun C; Bunchhoeung PDT; Huerga H; Loarec A; Dousset JP; Marquardt T; Paih ML; Maman D
    BMC Infect Dis; 2021 Feb; 21(1):223. PubMed ID: 33637051
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Seroprevalence of hepatitis C virus (HCV) antibodies and associated factors based on voluntary screening data collection in the general population in Benin in 2016].
    Kpossou AR; Kouwakanou B; Sokpon CNDM; Alassane KS; Bankolé MM; Ahouada C; Vignon RK; Zoundjiekpon V; Sourokou F; Séhonou J; Kodjoh N
    Pan Afr Med J; 2021; 40():30. PubMed ID: 34733398
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Estimation of State-Level Prevalence of Hepatitis C Virus Infection, US States and District of Columbia, 2010.
    Rosenberg ES; Hall EW; Sullivan PS; Sanchez TH; Workowski KA; Ward JW; Holtzman D
    Clin Infect Dis; 2017 Jun; 64(11):1573-1581. PubMed ID: 28449115
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High frequency of active HCV infection among seropositive cases in west Africa and evidence for multiple transmission pathways.
    Layden JE; Phillips RO; Owusu-Ofori S; Sarfo FS; Kliethermes S; Mora N; Owusu D; Nelson K; Opare-Sem O; Dugas L; Luke A; Shoham D; Forbi JC; Khudyakov YE; Cooper RS
    Clin Infect Dis; 2015 Apr; 60(7):1033-41. PubMed ID: 25477425
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A nationwide cross-sectional review of in-hospital hepatitis B virus testing and disease burden estimation in Ghana, 2016 - 2021.
    Nartey YA; Okine R; Seake-Kwawu A; Ghartey G; Asamoah YK; Senya K; Duah A; Owusu-Ofori A; Amugsi J; Suglo D; Bampoh SA; Hiebert L; Njuguna H; Ward JW; Plymoth A; Roberts LR; Bockarie AS; Awuku YA; Obiri-Yeboah D
    BMC Public Health; 2022 Nov; 22(1):2149. PubMed ID: 36419017
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Seroprevalence and risk factors of HBV, HCV and HIV among hemodialysis patients: a multicenter cross-sectional study from Damascus Syria.
    Altinawe J; Akkawi ME; Kharrat Helu N; Hassan Q; Nattouf AH
    BMC Infect Dis; 2024 Mar; 24(1):289. PubMed ID: 38448805
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevalence and risk factors of hepatitis B and C virus infections among the general population and blood donors in Morocco.
    Baha W; Foullous A; Dersi N; They-they TP; El alaoui K; Nourichafi N; Oukkache B; Lazar F; Benjelloun S; Ennaji MM; Elmalki A; Mifdal H; Bennani A
    BMC Public Health; 2013 Jan; 13():50. PubMed ID: 23331910
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hepatitis C virus core antigen is cost-effective in community-based screening of active hepatitis C infection in Taiwan.
    Wang JH; Chen CH; Chang CM; Feng WC; Lee CY; Lu SN
    J Formos Med Assoc; 2020 Jan; 119(1 Pt 3):504-508. PubMed ID: 31350109
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevalence of antibodies against hepatitis C virus and hepatitis B coinfection in healthy population in Bulgaria. A seroepidemiological study.
    Atanasova MV; Haydouchka IA; Zlatev SP; Stoilova YD; Iliev YT; Mateva NG
    Minerva Gastroenterol Dietol; 2004 Mar; 50(1):89-96. PubMed ID: 15719010
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Community seroprevalence of hepatitis B, C and human immunodeficiency virus in adult population in gojjam zones, northwest Ethiopia.
    Abera B; Adem Y; Yimer M; Mulu W; Zenebe Y; Mekonnen Z
    Virol J; 2017 Feb; 14(1):21. PubMed ID: 28166829
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Seroprevalence of hepatitis B and C infection among the HIV-positive population in Abuja, Nigeria.
    Tremeau-Bravard A; Ogbukagu IC; Ticao CJ; Abubakar JJ
    Afr Health Sci; 2012 Sep; 12(3):312-7. PubMed ID: 23382745
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Correlates of hepatitis C virus infection among incarcerated Ghanaians: a national multicentre study.
    Adjei AA; Armah HB; Gbagbo F; Ampofo WK; Quaye IKE; Hesse IFA; Mensah G
    J Med Microbiol; 2007 Mar; 56(Pt 3):391-397. PubMed ID: 17314372
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Maternal hepatitis C (HCV) infection and Anti-D immunoglobulin therapy: study testing antibodies, RNA and Genotype of HCV in Baghdad.
    Al-Kubaisy W; Daud S; Al-Kubaisi MW; Al-Kubaisi OW; Abdullah NN
    J Matern Fetal Neonatal Med; 2019 Oct; 32(20):3464-3469. PubMed ID: 29656685
    [No Abstract]   [Full Text] [Related]  

  • 38. Hepatitis B and C infections in HIV-1 and non-HIV infected pregnant women in the Brong-Ahafo Region, Ghana.
    Frempong MT; Ntiamoah P; Annani-Akollor ME; Owiredu WKBA; Addai-Mensah O; Owiredu EW; Adu-Gyasi D; Agyapong EO; Sallah L
    PLoS One; 2019; 14(7):e0219922. PubMed ID: 31323077
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The seroprevalence of untreated chronic hepatitis C virus (HCV) infection and associated risk factors in male Irish prisoners: a cross-sectional study, 2017.
    Crowley D; Lambert JS; Betts-Symonds G; Cullen W; Keevans M; Kelly E; Laird E; McHugh T; McKiernan S; Miggin SJ; Murphy C; Murtagh R; O'Reilly D; Tobin C; Van Hout MC
    Euro Surveill; 2019 Apr; 24(14):. PubMed ID: 30968825
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Seroprevalence, risk factors, and hepatitis C virus genotypes in groups with high-risk sexual behavior in Croatia.
    Cavlek TV; Margan IG; Lepej SZ; Kolaric B; Vince A
    J Med Virol; 2009 Aug; 81(8):1348-53. PubMed ID: 19551819
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.